BackProtagenic Therapeutics- Warrants (13/04/2025) Overview

Protagenic Therapeutics- Warrants (13/04/2025) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for PTIXW.

Quarterly EBIT

-$925.10K
40.45% YoY

As of Dec 31, 2025

Annual EBIT (TTM)

-$8.31M
48.33% YoY

Trailing 12 months ending Dec 31, 2025

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)